Health ❯ Women's Health ❯ Menopause

Hormone Therapy

Estrogen Therapy FDA Regulations Treatment Options Alzheimer's Disease Risk Bone Health Testosterone Therapy Testosterone Sexual Health Personal Experiences Alzheimer's Disease Alternative Treatments Hormonal Impact on Bladder Health Contraception Awareness Local Estrogen Therapy Tirzepatide Cognitive Function Breast Cancer Risk Menopause Hormone Therapy Health Risks and Benefits Health Risks Estrogen and Progesterone Risks and Benefits Dementia Risk Estrogen Patches Bone Density Fracture Risk Medication Management Cardiovascular Disease

3 ARTICLES

last mo.

FDA Scrutinizes Testosterone Use for Menopausal Women

Experts said long-term safety and dosing remain unresolved, prompting calls for targeted trials, standardized products, clinician training, clearer coverage and better data

3 ARTICLES

last mo.

FDA Asks Drugmakers for More Data on Testosterone Use in Menopausal Women

10 ARTICLES

3mo ago

Estrogen-Only Menopausal Therapy Linked to Fewer Alzheimer’s Markers on Autopsy

4 ARTICLES

4mo ago

Study Finds Menopausal Hormone Therapy Tied to 69% Lower Odds of Low Bone Density

3 ARTICLES

6mo ago

FDA Says Estrogen Patches Not in Official Shortage as Pharmacies Report Scarcity

3 ARTICLES

11mo ago

FDA Lifts Broad Black-Box Warnings From Many Menopause Hormone Therapies

7 ARTICLES

11mo ago

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

6 ARTICLES

this yr.

FDA Removes Broad Boxed Warnings From Many Menopause Hormone Therapies

3 ARTICLES

last yr.

Timing of Menopause Hormone Therapy Linked to Divergent Alzheimer’s Risks

4 ARTICLES

last yr.

Estradiol Therapy Route Tied to Different Memory Skills After Menopause, Study Finds

5 ARTICLES

last yr.

FDA Begins Expert Review of Menopause Hormone Therapy Warnings